Literature DB >> 15175443

Two steps forward in the treatment of colorectal cancer.

Robert J Mayer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15175443     DOI： 10.1056/NEJMe048098

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  30 in total

Review 1.  Skeletal Blood Flow in Bone Repair and Maintenance.

Authors:  Ryan E Tomlinson; Matthew J Silva
Journal:  Bone Res       Date:  2013-12-31       Impact factor: 13.567

2.  Antiangiogenesis cocktails - stirred or shaken?

Authors:  Sara M Mariani
Journal:  MedGenMed       Date:  2004-10-20

3.  Tumor recovery by angiogenic switch from sprouting to intussusceptive angiogenesis after treatment with PTK787/ZK222584 or ionizing radiation.

Authors:  Ruslan Hlushchuk; Oliver Riesterer; Oliver Baum; Jeanette Wood; Guenther Gruber; Martin Pruschy; Valentin Djonov
Journal:  Am J Pathol       Date:  2008-09-11       Impact factor: 4.307

4.  Utilization of bevacizumab in US elderly patients with colorectal cancer receiving chemotherapy.

Authors:  Alex Z Fu; Huei-Ting Tsai; John L Marshall; Andrew N Freedman; Arnold L Potosky
Journal:  J Oncol Pharm Pract       Date:  2013-10-11       Impact factor: 1.809

5.  Public voices in pharmaceutical deliberations: negotiating "clinical benefit" in the FDA's Avastin Hearing.

Authors:  Christa B Teston; S Scott Graham; Raquel Baldwinson; Andria Li; Jessamyn Swift
Journal:  J Med Humanit       Date:  2014-06

6.  Increase of survival benefit in advanced resectable colon cancer by extent of adjuvant treatment: results of a randomized trial comparing modulation of 5-FU + levamisole with folinic acid or with interferon-alpha.

Authors:  Karl-Heinz Link; Marko Kornmann; Ludger Staib; Martin Redenbacher; Martina Kron; Hans Günter Beger
Journal:  Ann Surg       Date:  2005-08       Impact factor: 12.969

7.  Colorectal cancer prognosis twenty years later.

Authors:  Luis Bujanda; Cristina Sarasqueta; Elisabeth Hijona; Lander Hijona; Angel Cosme; Ines Gil; Jose Luis Elorza; Jose I Asensio; Santiago Larburu; José M Enríquez-Navascués; Rodrigo Jover; Francesc Balaguer; Xavier Llor; Xavier Bessa; Montserrat Andreu; Artemio Paya; Antoni Castells
Journal:  World J Gastroenterol       Date:  2010-02-21       Impact factor: 5.742

8.  Colon cancer patient information seeking and the adoption of targeted therapy for on-label and off-label indications.

Authors:  Stacy W Gray; Katrina Armstrong; Angela Demichele; J Sanford Schwartz; Robert C Hornik
Journal:  Cancer       Date:  2009-04-01       Impact factor: 6.860

9.  Increased tumor oxygenation and drug uptake during anti-angiogenic weekly low dose cyclophosphamide enhances the anti-tumor effect of weekly tirapazamine.

Authors:  J C Doloff; N Khan; J Ma; E Demidenko; H M Swartz; Y Jounaidi
Journal:  Curr Cancer Drug Targets       Date:  2009-09       Impact factor: 3.428

Review 10.  Cost considerations in the treatment of colorectal cancer.

Authors:  Frank G A Jansman; Maarten J Postma; Jacobus R B J Brouwers
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.